Multiple site testing evaluation, Lancing device. ascensia, Reeze – Bayer HealthCare Ascensia BREEZE and Ascensia AUTODISCTM Unique 10-Test Disc User Manual
Page 43: Icrolet, Aculance

MULTIPLE SITE TESTING EVALUATION:
Forty-one persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia
®
B
REEZE
™ System and one test strip lot (Lot A). A
fingerstick was performed with the M
ICROLET
®
Adjustable
Lancing Device. Samples from the palm, forearm, thigh and
abdomen were obtained using the M
ICROLET
®
V
ACULANCE
Lancing Device. Ascensia
®
B
REEZE
™ results from the multiple
sites were compared to those obtained from the finger. The
blood glucose range for the fingerstick measurements was
3.3 to 13.6 mmol/L, with an average of 7.5 mmol/L. The
hematocrit range was 38 to 53%, with an average of 45%.
37
0
5
1 0
1 5
2 0
1 0
1 5
5
0
2 0
Ascensia
®
B
REEZE
™
Finger Stick Result (mmol/L)
y=x
0
5
1 0
1 5
2 0
0
5
1 0
1 5
2 0
y=x
Ascensia
®
B
REEZE
™
Palm Result (mmol/L)
Ascensia
®
B
REEZE
™ Forearm Result (mmol/L)
Ascensia
®
B
REEZE
™
Finger Stick Result (mmol/L)
A. Results from Palm (n = 36)
B. Results from Forearm (n = 30)